DR. SAMY K METYAS MD NPI 1831104694

NPI Details

DR. Samy K Metyas, MD is a rheumatology internal medicine in Covina, CA with 37 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. DR. Samy K Metyas, MD NPI is 1831104694. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

500 W SAN BERNARDINO RD STE A
COVINA, CA
ZIP 91722-797
Phone: (626) 966-1909
Fax: (626) 966-2629

The NPI 1831104694 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The CLIA number assigned to this NPI record is 05D2036327 - physician office with a certificate type of Certificate of Compliance.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
• Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg (HCPCS:J7318)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Beta 2 glycoprotein 1 antibody (autoantibody) measurement (HCPCS:86146)
• Cardiolipin antibody (tissue antibody) measurement (HCPCS:86147)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Analysis of substance using immunoassay technique, multiple step method (HCPCS:83516)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Vitamin d-3 level (HCPCS:82306)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Rheumatoid factor level (HCPCS:86431)
• Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
• Measurement of dna antibody, native or double stranded (HCPCS:86225)
• Measurement of dna antibody, single stranded (HCPCS:86226)
• Microsomal antibodies (autoantibody) measurement (HCPCS:86376)
• Thyroglobulin (thyroid protein) antibody measurement (HCPCS:86800)
• X-ray of hand, 2 views (HCPCS:73120)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg (HCPCS:J0702)
• X-ray of wrist, 2 views (HCPCS:73100)
• X-ray of knee, 1-2 views (HCPCS:73560)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• X-ray of foot, 2 views (HCPCS:73620)
• X-ray of ankle, 2 views (HCPCS:73600)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Injection of trigger points, 3 or more muscles (HCPCS:20553)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
• X-ray of lower and sacral spine, 2-3 views (HCPCS:72100)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• X-ray of hip, 2-3 views (HCPCS:73502)
• X-ray of upper spine, 2-3 views (HCPCS:72040)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose (HCPCS:J7321)
• Tuberculosis test, gamma interferon (HCPCS:86480)
• X-ray of shoulder, minimum of 2 views (HCPCS:73030)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Complete ultrasound scan of joint (HCPCS:76881)
• Aspiration and/or injection of fluid from small joint (HCPCS:20600)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
• Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes (HCPCS:99421)
• Injection into tendon or ligament (HCPCS:20550)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• X-ray of chest, 2 views (HCPCS:71046)
• X-ray of middle spine, 2 views (HCPCS:72070)
• Hyaluronan or derivative, monovisc, for intra-articular injection, per dose (HCPCS:J7327)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Complete ultrasound scan of abdomen (HCPCS:76700)
• X-ray of joint between lower spine and hip bone, 3 or more views (HCPCS:72202)
• Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free (HCPCS:90674)
• Influenza vaccine, quadrivalent, 0.5 ml dosage (HCPCS:90688)
• Ultrasound of leg arteries or artery grafts (HCPCS:93925)
• Ultrasound study of arm or leg veins with compression and maneuvers (HCPCS:93970)
• Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes (HCPCS:99422)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)

The enumeration date for this NPI number is 7/30/2006 and was last updated on 10/31/2016.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.